企業の倫理的ジレンマAIアドバイザー

家

AIプロンプト一覧

哲学/宗教

倫理的意思決定支援

${:__('collect %s',倫理的意思決定支援)}$

哲学/宗教

事業運営における道徳的ジレンマに対し、功利主義と義務論に基づくバランスの取れた分析を提供し、管理者がコンプライアンスと社会的責任を兼ね備えた意思決定を行うのを支援します。

プロンプト内容

コピー

Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has minor but under-disclosed side effects with long-term use. Continuing sales increases profit but may harm some patients, while recalling it causes massive losses and job cuts. Please evaluate the moral weight of both paths by combining the impact on overall well-being from utilitarianism with the emphasis on the duty of honest disclosure from deontology, and provide a balanced recommendation that considers legal compliance, corporate survival, and social responsibility, avoiding absolute moral judgments and instead offering a decision framework based on stakeholder analysis.

コピー

企業の倫理コンサルタントとして、以下の具体的なビジネスシナリオを分析してください：製薬会社が、長期使用で軽微だが十分に開示されていない副作用を持つベストセラー医薬品を発見しました。販売を継続すると利益は増えますが、一部の患者に害を与える可能性があります。リコールすると巨額の損失と雇用の削減を招きます。功利主義による全体的な幸福への影響と、義務論による正直な開示の義務への強調を組み合わせ、両者の道徳的重みを評価し、法的コンプライアンス、企業の存続、社会的責任を考慮したバランスの取れた推奨事項を提供してください。絶対的な道徳的判断を避け、ステークホルダー分析に基づく意思決定フレームワークを提供してください。

コピー

共有リンクをコピーするにはクリック

コメント (0)

0/300

送信

おすすめ

倫理的意思決定支援

Act as a corporate ethics consultant to conduct a deep moral analysis of the following specific business scenario: A pharmaceutical company discovers that its high-profit, already marketed drug has minor but long-term side effects. Recalling it would cause massive financial losses and affect shareholder interests, but not recalling it might harm some patients' health. Please evaluate the ethical weights of both recall and non-recall choices by combining two philosophical frameworks: utilitarianism (greatest happiness for the greatest number) and deontology (moral nature of the act itself, such as honesty and non-maleficence). Avoid simple binary judgments; instead, derive the best action path that is morally defensible and aligns with long-term Corporate Social Responsibility (CSR) by weighing the interests of various stakeholders (patients, shareholders, employees, society), and explain the reasoning.

倫理的意思決定支援

Act as a corporate ethics consultant to evaluate the following business scenario: A pharmaceutical company discovers its best-selling drug has minor but negligible side effects with long-term use, yet concealing this information would cause a stock crash and impact employee benefits. Analyze the moral risks of concealment using both utilitarian consequentialism and Kantian deontology, weigh shareholder interests against patient safety, and provide a decision recommendation that balances compliance with corporate social responsibility, ensuring logical consistency and adherence to business ethical standards.

倫理的意思決定支援

Act as a senior corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company developing a life-saving drug faces a dilemma regarding whether to partially release clinical trial data to accelerate approval, potentially sacrificing some subjects' privacy for greater public health benefits. Combine the utilitarian principle of maximizing happiness with the deontological respect for individual rights to evaluate the ethical risks of this decision. Provide a balanced solution that considers legal compliance, social responsibility, and long-term brand reputation, avoiding simple binary judgments, and focus on how to balance procedural justice with outcome justice.

倫理的意思決定支援

Please conduct an ethical analysis for the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has a minor but foreseeable side effect with long-term use, increasing cardiovascular risk for patients, but discontinuing the drug would cause病情 worsening for some dependent patients. Please evaluate whether the company should proactively recall the drug and disclose side effects, combining the utilitarian principle of maximizing happiness for the greatest number with the deontological requirement of respecting patient autonomy and informed consent. Weigh the short-term financial loss against long-term brand trust and legal liability from the perspectives of stakeholders (patients, shareholders, employees, public), and finally provide a specific action recommendation that balances moral responsibility and corporate sustainability, explaining how this recommendation balances the interests of all parties.

倫理的意思決定支援

Act as a senior corporate ethics consultant to conduct a moral deduction for the following specific business scenario: A pharmaceutical company discovers during clinical trials that a drug has minor but long-term neurological side effects, yet it significantly extends the survival of late-stage cancer patients with no alternative therapies. Please analyze how the company should balance shareholder interests, patient health rights, and social responsibility by combining the utilitarian principle of maximizing happiness with the deontological perspective of respecting patient autonomy and the duty of non-maleficence, specifically regarding whether informed consent forms should explicitly mention these side effects, and provide specific communication strategies and ethical decision-making advice ensuring rigorous logic and compliance with modern business ethics standards.

倫理的意思決定支援

Please analyze the following specific ethical dilemma encountered in business operations: A pharmaceutical company discovers that its best-selling drug has mild but predictable side effects with long-term use, affecting the quality of life for some elderly patients, but discontinuing the drug would lead to more severe health risks. Please evaluate the moral rationality of three options—continuing sales, modifying label warnings, or initiating a recall—by combining the utilitarian principle of maximizing happiness with the deontological requirement of respecting patient autonomy, and provide a balanced recommendation that considers both corporate responsibility and patient well-being, ensuring the analysis is logically rigorous and compliant with business ethics standards.